Companies /Healthcare
BridgeBio Pharma Inc
NASDAQ: BBIO Biotechnology
$64.90
▼ $1.60 (−2.41%) today
Markets open · 11:36am ET

BridgeBio Pharma (BBIO) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
17%
EPS beat rate
−33.01%
Avg. EPS surprise
Consecutive EPS misses
BBIO vs Market · 30-day return after each reportBBIOS&P 500
−10%0%+10%+20%−7.6%+6.9%Q1 25+21.2%+2.5%Q2 25+12.8%+0.3%Q3 25+4.8%−8.5%Q4 25+0.0%−1.7%Q1 26−13.5%−0.8%Q2 26
−10%0%+10%+20%Q1 25Q3 25Q1 26
BBIO EPS Trend · estimate vs actualEstimateActual
$-0.90$-0.60$-0.30$-1.00$-0.88Q1 25$-0.61$-0.95Q2 25$-0.78$-0.95Q3 25$-0.62$-1.00Q4 25$-0.62$-0.84Q1 26$-0.58$-0.78Q2 26
$-0.90$-0.60$-0.30Q1 25Q3 25Q1 26
BBIO Revenue Trend · estimate vs actualEstimateActual
$0$70.0M$140.0M$210.0M$57.7M$116.6MQ1 25$88.8M$110.6MQ2 25$105.7M$120.7MQ3 25$149.1M$154.2MQ4 25$178.6M$194.5MQ1 26$219.7M$243.7MQ2 26
$0$70.0M$140.0M$210.0MQ1 25Q3 25Q1 26

How Often Does BridgeBio Pharma Beat Earnings Estimates?

BridgeBio Pharma beat EPS estimates in 1 of its last 6 reported quarters, and has missed 5 quarters in a row.

BBIO quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $-0.78 est. $-0.58 −33.86% $243.7M est. $219.7M +10.91%
Q1 2026 $-0.84 est. $-0.62 −36.21% $194.5M est. $178.6M +8.90%
Q4 2025 $-1.00 est. $-0.62 −60.44% $154.2M est. $149.1M +3.42%
Q3 2025 $-0.95 est. $-0.78 −22.31% $120.7M est. $105.7M +14.23%
Q2 2025 $-0.95 est. $-0.61 −57.02% $110.6M est. $88.8M +24.54%
Q1 2025 $-0.88 est. $-1.00 +11.78% $116.6M est. $57.7M +102.06%

Figures from SEC filings and company reports. Not investment advice.